Publications and Digital Products

This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.

This report provides evidence-based practices for screening and assessment of adults in the justice system with mental illness, substance use disorders, or both. It discusses the importance of instrument selection for screening and assessment and provides detailed descriptions of recommended instruments.

This report discusses a technical expert panel convened to assess research about therapeutic services for youth living in foster care. It reviews the scientific evidence and expert panel input to identify action items and further research needs.

This quick guide helps administrators of substance use disorder treatment facilities implement programs and services that address the needs of women living with substance use disorders. It addresses patterns of use and the drug screening and treatment needs of women.

This guide helps substance use counselors treat clients with symptoms of depression and substance use conditions. Program administrators will learn how to integrate depression treatment into early drug treatment. The guidelines cover screening, assessment, treatment, counseling, cultural competence, and continuing care. 

This fact sheet offers strategies for suicide prevention. It provides facts about suicide, including its prevalence and at-risk populations. This resource also lists warning signs of suicidal behavior, and describes how to help someone who is at risk for suicide.

This manual offers treatment and service providers guidelines on caring for people living with substance use disorder conditions who also have physical disabilities or cognitive disabilities. It discusses screening, treatment planning, and counseling, and linkages with other treatment and service providers.

This manual offers guidelines for medication-assisted treatment for people, particularly veterans, living with post-traumatic stress disorder and co-occurring opioid use disorders. It covers screening, concomitant treatment, pharmacotherapy, and multiple misused substances.

This manual offers general principles to assist in the planning, delivery, and evaluation of pharmacologic approaches to support the recovery of people living with co-occurring disorders. It covers engagement, screening, assessment, treatment planning, and continuity of care.

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.